# NutriBand Inc.: filings

NTRB · Nasdaq · CIK 1676047 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/ntrb.md) · [Financials](/companies/ntrb/financials.md) · [Filings](/companies/ntrb/filings.md) · [Insiders](/companies/ntrb/insiders.md)

## Reports and events: 152 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 74, 10-Q 31, S-1/A 14, 5 13, 4 11, 424B3 11, 10-K 10, CORRESP 10, POS AM 8, UPLOAD 7, 8-K/A 6, DEF 14A 6, EFFECT 6, 10-12G/A 4, 424B4 4, NT 10-Q 4, S-1 4, D 3, DRS/A 3, RW 3, 10-K/A 2, 4/A 2, 5/A 2, DEF 14C 2, DRS 2, NT 10-K 2, SC 13G 2, SCHEDULE 13D 2, 10-12G 1, 25-NSE 1, 3 1, 8-A12B 1, CERT 1, DEL AM 1, FWP 1, PRE 14A 1, S-8 1, S-8 POS 1, SC 13D 1, SC 13D/A 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-23 | 17:27 ET | [8-K](/filings/0001213900-26-102721.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-102721 |
| 2026-09-15 | 15:48 ET | [SCHEDULE 13D/A](/filings/0001213900-26-100103.md) | Ownership report, active investor, amended | 0001213900-26-100103 |
| 2026-09-04 | 16:31 ET | [10-Q](/filings/0001213900-26-097701.md) | Quarterly report, period 2026-07-31 | 0001213900-26-097701 |
| 2026-06-22 | 08:02 ET | [8-K](/filings/0001213900-26-070378.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-070378 |
| 2026-06-11 | 16:20 ET | [10-Q](/filings/0001213900-26-067840.md) | Quarterly report, period 2026-04-30 | 0001213900-26-067840 |
| 2026-05-18 | 16:44 ET | [10-K/A](/filings/0001213900-26-058507.md) | Annual report, amended, period 2026-01-31 | 0001213900-26-058507 |
| 2026-04-29 | 17:13 ET | [10-K](/filings/0001213900-26-049399.md) | Annual report, period 2026-01-31 | 0001213900-26-049399 |
| 2026-04-07 | 15:43 ET | [8-K](/filings/0001213900-26-041006.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-041006 |
| 2026-02-13 | 16:58 ET | [8-K](/filings/0001213900-26-016550.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-016550 |
| 2026-02-03 | 13:44 ET | [8-K](/filings/0001213900-26-011304.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-011304 |
| 2025-12-30 | 16:28 ET | [8-K](/filings/0001213900-25-126650.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-126650 |
| 2025-12-19 | 11:01 ET | [DEF 14A](/filings/0001213900-25-123599.md) | Proxy statement, period 2026-01-24 | 0001213900-25-123599 |
| 2025-12-11 | 17:41 ET | [10-Q](/filings/0001213900-25-120204.md) | Quarterly report, period 2025-10-31 | 0001213900-25-120204 |
| 2025-10-28 | 12:00 ET | [8-K](/filings/0001213900-25-102930.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-102930 |
| 2025-09-09 | 17:27 ET | [10-Q](/filings/0001213900-25-086270.md) | Quarterly report, period 2025-07-31 | 0001213900-25-086270 |
| 2025-09-03 | 13:06 ET | [8-K](/filings/0001213900-25-083882.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-083882 |
| 2025-08-07 | 16:47 ET | [8-K](/filings/0001213900-25-073116.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-073116 |
| 2025-07-16 | 17:54 ET | [8-K](/filings/0001213900-25-064355.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-064355 |
| 2025-05-30 | 16:02 ET | [10-Q](/filings/0001213900-25-049455.md) | Quarterly report, period 2025-04-30 | 0001213900-25-049455 |
| 2025-05-13 | 17:29 ET | [10-K/A](/filings/0001213900-25-042792.md) | Annual report, amended, period 2025-01-31 | 0001213900-25-042792 |
| 2025-04-28 | 17:21 ET | [10-K](/filings/0001213900-25-036201.md) | Annual report, period 2025-01-31 | 0001213900-25-036201 |
| 2025-04-09 | 11:41 ET | [8-K](/filings/0001213900-25-030175.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-030175 |
| 2025-03-13 | 18:10 ET | [SCHEDULE 13D](/filings/0001213900-25-023797.md) | Ownership report, active investor | 0001213900-25-023797 |
| 2025-03-13 | 18:07 ET | [SCHEDULE 13D](/filings/0001213900-25-023793.md) | Ownership report, active investor | 0001213900-25-023793 |
| 2025-02-13 | 11:59 ET | [8-K](/filings/0001213900-25-013266.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-013266 |
| 2025-02-12 | 16:12 ET | [8-K](/filings/0001213900-25-012896.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-012896 |
| 2025-01-29 | 17:22 ET | [8-K](/filings/0001213900-25-007938.md) | 5.07 Shareholder vote results | 0001213900-25-007938 |
| 2024-12-30 | 15:59 ET | [8-K](/filings/0001213900-24-113463.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-113463 |
| 2024-12-16 | 11:35 ET | [DEF 14A](/filings/0001213900-24-109109.md) | Proxy statement, period 2025-01-23 | 0001213900-24-109109 |
| 2024-12-04 | 20:47 ET | [10-Q](/filings/0001213900-24-105201.md) | Quarterly report, period 2024-10-31 | 0001213900-24-105201 |
| 2024-10-31 | 12:38 ET | [8-K](/filings/0001213900-24-092676.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-092676 |
| 2024-09-19 | 11:38 ET | [SC 13D/A](/filings/0001213900-24-080124.md) | Ownership report, active investor, amended | 0001213900-24-080124 |
| 2024-09-18 | 13:51 ET | [8-K](/filings/0001213900-24-079788.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-079788 |
| 2024-09-03 | 17:12 ET | [10-Q](/filings/0001213900-24-075159.md) | Quarterly report, period 2024-07-31 | 0001213900-24-075159 |
| 2024-06-03 | 15:25 ET | [8-K/A](/filings/0001213900-24-049007.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-24-049007 |
| 2024-05-31 | 13:54 ET | [10-Q](/filings/0001213900-24-048363.md) | Quarterly report, period 2024-04-30 | 0001213900-24-048363 |
| 2024-05-21 | 18:16 ET | [8-K](/filings/0001213900-24-045330.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-24-045330 |
| 2024-05-17 | 17:44 ET | [8-K](/filings/0001213900-24-044425.md) | 5.02 Departure or appointment of officers or directors | 0001213900-24-044425 |
| 2024-05-01 | 18:51 ET | [10-K](/filings/0001213900-24-037996.md) | Annual report, period 2024-01-31 | 0001213900-24-037996 |
| 2024-04-23 | 14:01 ET | [8-K](/filings/0001213900-24-035276.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-035276 |
| 2024-03-28 | 17:14 ET | [8-K](/filings/0001213900-24-027338.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-027338 |
| 2024-01-25 | 16:40 ET | [8-K](/filings/0001213900-24-006496.md) | 5.07 Shareholder vote results | 0001213900-24-006496 |
| 2024-01-23 | 10:53 ET | [SC 13D](/filings/0001213900-24-005531.md) | Ownership report, active investor | 0001213900-24-005531 |
| 2024-01-11 | 17:07 ET | [8-K](/filings/0001213900-24-003023.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-003023 |
| 2023-12-29 | 17:25 ET | [8-K](/filings/0001213900-23-100093.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-23-100093 |
| 2023-12-15 | 17:49 ET | [DEF 14A](/filings/0001213900-23-095793.md) | Proxy statement, period 2024-01-21 | 0001213900-23-095793 |
| 2023-12-13 | 21:05 ET | [10-Q](/filings/0001213900-23-095208.md) | Quarterly report, period 2023-10-31 | 0001213900-23-095208 |
| 2023-09-11 | 18:00 ET | [10-Q](/filings/0001213900-23-075508.md) | Quarterly report, period 2023-07-31 | 0001213900-23-075508 |
| 2023-07-14 | 09:15 ET | [8-K](/filings/0001213900-23-056939.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-23-056939 |
| 2023-07-06 | 21:56 ET | [S-1/A](/filings/0001213900-23-054976.md) | Registration statement, amended | 0001213900-23-054976 |

Page 1 of 4. [Older](/companies/ntrb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.